Asthma
Conference Coverage
Digital monitors can relieve asthma burden by boosting medication adherence and inhaler technique
From the Journals
New gene signals for asthma-COPD overlap identified
Conference Coverage
Asthma: Easy strategy reduces exacerbations, improves control
From the Journals
Omalizumab curbs airway inflammation in severe asthma
From the Journals
Asthma treatment does not appear to raise risk of neuropsychiatric disease
The FDA has previously warned of the risk for neuropsychiatric drug reactions for leukotriene receptor antagonists – including a boxed warning for...
News
FDA approves cabotegravir LA; New HIV PrEP option fills an important gap
“Being able to offer an injectable option is ... a game changer,” said Dr. Lina Rosengren-Hovee of UNC Health.
News from the FDA/CDC
FDA approves tezepelumab-ekko (Tezspire) for severe asthma
“Tezspire represents a much-needed new treatment for the many patients who remain underserved and continue to struggle with severe, uncontrolled...
Feature
COVID-19 has brought more complex, longer office visits
Patients’ increased mental health needs and worsened chronic conditions have practices playing catch-up and expanding teams to ease demand.
From the Journals
Itepekimab reduces loss of asthma control
From the Journals
Placebo beat risankizumab in adults with severe asthma
From the Journals
Synthetic chemical in consumer products linked to early death, study says
Daily exposure to phthalates may lead to hundreds of thousands of early deaths each year among older adults in the United States.